In this work, two human induced pluripotent stem cell (iPSC) lines were generated from STGD1 patients carrying compound heterozygous mutations in ABCA4.
The 1st human patient-specific tissue-engineered model of the neuromuscular junction that combines stem cell technology with tissue engineering, optogenetics, microfabrication and image processing.
Generation of an iPSC line from the skin fibroblasts of a patient affected by a genetic eye disease, Retinitis Pigmentosa, presenting with two mutations in the USH2A gene.
We have generated an induced pluripotent stem cell (iPSC) line derived from a RP patient with two heterozygous mutations in the cGMP-specific phosphodiesterase 6A alpha subunit (PDE6A) gene.
